Document is current
Any future updates will be listed below
-
Authors
Moretti, B. https://orcid.org/0000-0002-1234-8616
Spinarelli, A. https://orcid.org/0000-0003-2183-2191
Varrassi, G. https://orcid.org/0000-0002-3822-2923
Massari, L. https://orcid.org/0000-0001-6198-2122
Gigante, A. https://orcid.org/0000-0003-0772-563X
Iolascon, G. https://orcid.org/0000-0002-0976-925X
Benedetti, M. G.
Moretti, A. M. https://orcid.org/0000-0001-6285-478X
-
Funding
Funding for this research was provided by:
Angelini Pharma (00000)
- License Information
-
More Information
Article History
Received: 19 April 2021
Accepted: 25 July 2021
First Online: 7 August 2021
Declarations
:
: G. Varrassi is a consultant for Abbott, Angelini, Dompé, Grünenthal, Malesci, Menarini, Molteni, Pfizer, Shonogi, and Takeda. He has received research grants from Dompé, the Fondazione Internazionale Maugeri, and the Consiglio Nazionale per la Ricerca. He also serves on the Editorial Board of several scientific journals and is the Editor and Chief of Pain and Therapy. The other authors declare that they have no competing interests.
